4Seitz JF, Duffaud F, Dahan L, et al. Adenocarcinomas of the distal esophagus and gastric cardia: what chemotherapy or chemoradiotherapy for recurrent or metastatic disease? [ J ]. Cancer Radiother, 2001,5 : 107 - 112.
5Tahara M, Ohtsu A. Latest progress on chemotherapy for advanced gastric cancer[ J ]. Gan To Kagaku Ryoho ,2000, 27 ( 13 ) :2048 - 2058.
6Yamada Y, Shirao K, Ohtsu A, et al. Phase Ⅱ trial of paclitaxel by three - hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel -associated hypersensitivity reactions [ J]. Ann Oncol, 2001,12(8) :1133 - 1137.
7Kodera Y, Ito S,Mochizuki Y, et al. A phase Ⅱ study of weekly paclitaxel as second - line chemotherapy for advanced gastric Cancer ( CCOG0302 study) [ J ]. Anticancer Res ,2007,27 (4C) :2667 - 2671.
8Lee KW, Kim JH, Yun T, et al. Phase Ⅱ study of low - dose paclitaxel and cisplatin as a second - line therapy after 5 - fluorouracil/platinum chemotherapy in gastric cancer [J]. J Korean Med Sci,2007,22 :S115 -S121.
9Lokich J J, Ahlgren JD, Gullo J J, et al. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid -Atlantic Oncology Program Study [ J ]. J Clin Oncol, 1989,7 (4) :425 - 432.
10Shirasaka T, Shimamoto Y, Ohshimo H, et al. Metabolic basis of the synergistic antitumor activities of 5 - fluorouracil and cisplatin in rodent tumor models in vivo [ J ]. Cancer Chemother Pharmacol, 1993,32 ( 3 ) : 167 - 172.
